Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FE856
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $154,087
Award facts
- Contract value 100% obligated
- $154,086.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $154,086.60 to AmerisourceBergen Drug Corp on December 23, 2025, for pharmaceutical products and medical supplies to support federal medical procurement needs. This firm fixed price delivery order, issued under a non-competitive set-aside designation, is scheduled for completion by January 15, 2026, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999.99 million ceiling value through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, leverages this prime IDC to supply a broad range of pharmaceuticals and medical commodities—including brand-name and generic medications, vaccines, specialty treatments, and medical devices—to support Defense Health Agency operations and other federal healthcare systems worldwide. The company's demonstrated capability to meet federal procurement requirements through open competition, combined with its extensive portfolio of therapeutic products spanning diabetes management, neurological treatments, pain management, and antibiotics, positions it as a critical vendor for DLA's medical supply chain operations.
Quick answers
Who was awarded contract SPE2DU26FE856?
SPE2DU26FE856 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 23, 2025.
How much is contract SPE2DU26FE856 worth?
The government has obligated $154,087 on SPE2DU26FE856.
Is contract SPE2DU26FE856 an order under another contract?
Yes. SPE2DU26FE856 is a delivery order under SPE2DU25D5117, an indefinite delivery contract.
Was contract SPE2DU26FE856 competed?
The extent of competition for SPE2DU26FE856 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award